EUVIMEDEUVIMED entdecken
Crossref

Design, synthesis, and biological evaluation of novel quinoxaline aryl ethers as anticancer agents

Srinuvasu Nakka, Asif Raza, Kosana Sai Chaitanya, Naga Venkata Madhusudhan Rao Bandaru, Ala Chandu, Sankaranarayanan Murugesan iD, Nagaraju Devunuri, Arun K Sharma, Kondapalli Venkata Gowri Chandrasekhar iD

Chemical Biology & Drug Design · 2024-03 · 103 (3)

DOI: 10.1111/cbdd.14502 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Chemical Biology & Drug Design, online erschienen am 07.03.2024. Verfasst von Srinuvasu Nakka und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, School of Applied Sciences and Humanities, Vignan's Foundation for Science Technology and Research University (VFSTR), Guntu…. Hauptthemen laut MEDLINE: Ethers, Antineoplastic Agents. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 40 Literaturangaben. Gefördert von: Council for Scientific and Industrial Research (CSIR), New Delhi (F.No. 02(392)/21/EMRII), Council for Scientific and Industrial Research (CSIR), New Delhi (F.No. 02/0477/23/EMRII).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

We designed and synthesized thirty novel quinoxaline aryl ethers as anticancer agents, and the structures of final compounds were confirmed with various analytical techniques like Mass, 1 H NMR, 13 C NMR, FTIR, and elemental analyses. The compounds were tested against three cancer cell lines: colon cancer (HCT‐116), breast cancer (MDA‐MB‐231), prostate cancer (DU‐145), and one normal cell line: human embryonic kidney cell line (HEK‐293). The obtained results indicate that two compounds, FQ and MQ, with IC 50 values < 16 μM, were the most active compounds. Molecular docking studies revealed the binding of FQ and MQ molecules in the active site of the c‐Met kinase (PDB ID: 3F66, 1.40 Å). Furthermore, QikProp ADME prediction and the MDS analysis preserved those critical docking data of both compounds, FQ and MQ . Western blotting was used to confirm the impact of the compounds FQ and MQ on the inhibition of the c‐Met kinase receptor. The apoptosis assays were performed to investigate the mechanism of cell death for the most active compounds, FQ and MQ . The Annexin V/7‐AAD assay indicated apoptosis in MDA‐MB‐231 cells treated with FQ and MQ , with FQ (21.4%) showing a higher efficacy in killing MDA‐MB‐231 cells than MQ (14.25%). The Caspase 3/7 7‐AAD assay further supported these findings, revealing higher percentages of apoptotic cells for FQ ‐treated MDA‐MB‐231 cells (41.8%). The results obtained from the apoptosis assay conclude that FQ exhibits better anticancer activity against MDA‐MB‐231 cells than MQ .

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

EthersAntineoplastic AgentsHumansCell Line, TumorMolecular Docking SimulationQuinoxalinesHEK293 CellsCell ProliferationDrug Screening Assays, AntitumorApoptosisMolecular StructureStructure-Activity Relationship

Stichwörter der Autor:innen

anticancerapoptosis assaycytotoxicitymolecular dockingmolecular dynamicsquinoxalines

Substanzen

EthersQuinoxalinesAntineoplastic Agents

Autor:innen und Institutionen

  • Department of Chemistry, School of Applied Sciences and Humanities, Vignan's Foundation for Science Technology and Research University (VFSTR), Guntur, Andhra Pradesh, India.
  • Department of Pharmacology, Penn State Cancer Institute, Penn State College of Medicine, 500 University Drive, Hershey, Pennsylvania, USA.
  • Department of Chemistry, Birla Institute of Technology and Science, Hyderabad Campus, Hyderabad, Telangana, India.
  • Department of Pharmacy, Medicinal Chemistry Research Laboratory, Birla Institute of Technology and Science Pilani, Pilani Campus, Pilani, Rajasthan, India.

ORCID-Profile: Sankaranarayanan Murugesan, Kondapalli Venkata Gowri Chandrasekhar

Förderung

  • Council for Scientific and Industrial Research (CSIR), New Delhi (F.No. 02(392)/21/EMRII)
  • Council for Scientific and Industrial Research (CSIR), New Delhi (F.No. 02/0477/23/EMRII)

Zitieren

APA

Nakka, S., Raza, A., Chaitanya, K. S., Bandaru, N. V. M. R., Chandu, A., Murugesan, S., Devunuri, N., Sharma, A. K., & Chandrasekhar, K. V. G. (2024). Design, synthesis, and biological evaluation of novel quinoxaline aryl ethers as anticancer agents. Chemical Biology & Drug Design, 103(3). https://doi.org/10.1111/cbdd.14502

Vancouver

Nakka S, Raza A, Chaitanya KS, Bandaru NVMR, Chandu A, Murugesan S, et al. Design, synthesis, and biological evaluation of novel quinoxaline aryl ethers as anticancer agents. Chemical Biology & Drug Design. 2024;103(3). doi:10.1111/cbdd.14502

BibTeX
@article{Nakka2024,
  author = {Nakka, Srinuvasu and Raza, Asif and Chaitanya, Kosana Sai and Bandaru, Naga Venkata Madhusudhan Rao and Chandu, Ala and Murugesan, Sankaranarayanan and Devunuri, Nagaraju and Sharma, Arun K and Chandrasekhar, Kondapalli Venkata Gowri},
  title = {Design, synthesis, and biological evaluation of novel quinoxaline aryl ethers as anticancer agents},
  journal = {Chemical Biology & Drug Design},
  year = {2024},
  volume = {103},
  number = {3},
  doi = {10.1111/cbdd.14502}
}
Kostenlos starten →